NexImmune, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
NexImmune, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q2 2024.
  • NexImmune, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.33M, a 69.2% increase year-over-year.
  • NexImmune, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$20.6M, a 57.7% increase year-over-year.
  • NexImmune, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$32.3M, a 48.3% increase from 2022.
  • NexImmune, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$62.5M, a 22.8% decline from 2021.
  • NexImmune, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$50.9M, a 70.4% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$20.6M -$2.33M +$5.24M +69.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$25.9M -$3.08M +$6.49M +67.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-07
Q4 2023 -$32.3M -$5.36M +$11.5M +68.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 -$43.9M -$9.85M +$4.88M +33.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-17
Q2 2023 -$48.8M -$7.57M +$8.29M +52.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$57M -$9.57M +$5.46M +36.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-07
Q4 2022 -$62.5M -$16.9M -$1.37M -8.81% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 -$61.1M -$14.7M -$82.3K -0.56% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-17
Q2 2022 -$61.1M -$15.9M -$3.68M -30.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$57.4M -$15M -$6.48M -75.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$50.9M -$15.5M -$7.51M -93.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$43.4M -$14.6M -$6.04M -70.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$37.3M -$12.2M -$5.25M -75.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$32.1M -$8.55M -$2.23M -35.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$29.9M -$8.01M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-09
Q3 2020 -$8.61M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$6.93M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$6.32M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.